Cargando…
Antiganglioside antibodies and paraneoplastic neuromuscular junction disorder?
Based on the instructions in “Guide for authors”, our manuscript is a case reports and was submitted under “Letters to the Editor”, which should not include an abstract.
Autores principales: | Jazebi, Noushin, Patel, Chilvana, Fang, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548416/ https://www.ncbi.nlm.nih.gov/pubmed/33072897 http://dx.doi.org/10.1016/j.ensci.2020.100277 |
Ejemplares similares
-
Presynaptic Paraneoplastic Disorders of the Neuromuscular Junction: An Update
por: Giannoccaro, Maria Pia, et al.
Publicado: (2021) -
Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma
por: Ene, Corina Daniela, et al.
Publicado: (2020) -
Investigation on antigangliosides antibodies in asymptomatic HIV patients
por: Nicolae, Ilinca, et al.
Publicado: (2014) -
Physiology of gangliosides and the role of antiganglioside antibodies in human diseases
por: Cutillo, Gianni, et al.
Publicado: (2020) -
Nivolumab treatment followed by atezolizumab induced encephalitis and neuropathy with antiganglioside antibodies
por: Watanabe, Shohei, et al.
Publicado: (2021)